This book describes the theories, applications, and challenges for different oral controlled release formulations. This book differs from most in its focus on oral controlled release formulation design and process development. It also covers the related areas like preformulation, biopharmaceutics, in vitro in vivo correlations (IVIVC), quality by design (QbD), and regulatory issues.
This book describes the theories, applications, and challenges for different oral controlled release formulations. This book differs from most in its focus on oral controlled release formulation design and process development. It also covers the related areas like preformulation, biopharmaceutics, in vitro in vivo correlations (IVIVC), quality by design (QbD), and regulatory issues.
HONG WEN, PhD, is a Fellow and Project Leader in the Department of Pharmaceutical Development at Novartis, as well as a core member of the Novartis TRD S&T committee. He has contributed to dozens of INDs/IMPDs in addition to several approved NDAs. His expertise spans from discovery support and preformulation to late-phase development of solid dosage forms. He also specializes in bioavailability enhancement for water insoluble drugs, oral sustained release (SR) formulations, and combination products (FDC). He has written fifteen publications, six presentations, and eight patents in the drug delivery and controlled release fields. KINAM PARK, PhD, is a Professor in the Department of Pharmaceutics and Showalter Distinguished Professor of Biomedical Engineering at Purdue University. He is also the President of Akina, Inc., specializing in drug delivery. Dr. Park is Editor-in-Chief of the Journal of Controlled Release among other journal and advisory board appointments. The recipient of the Controlled Release Society Founders Award in 2004, Dr. Park has published nine books, more than a hundred chapters, and more than two hundred journal articles, and holds sixteen patents.
Inhaltsangabe
Preface. Contributors. 1 Introduction and Overview of Oral Controlled Release Formulation Design (Hong Wen and Kinam Park). 2 Evolution of Oral Controlled Release Dosage Forms (Ping I. Lee and Jian-Xin Li). 3 Biopharmaceutic Consideration and Assessment for Oral Controlled Release (CR) Formulations (Hua Zhang and Jean M. Surian). 4 Preformulation Consideration for Drugs in Oral CR Formulation (Manching Sherry Ku). 5 Polymers in Oral Modified Release Systems (Jiasheng Tu, Yan Shen, Ravichandran Mahalingam, Bhaskara Jasti, and Xiaoling Li). 6 Oral Extended Release Hydrophilic Matrices: Formulation and Design (Xiaoguang Wen, Ali Nokhodchi, and Ali Rajabi-Siahboomi). 7 Coating Systems for Oral Controlled Release Formulations (Linda A. Felton). 8 Fluid Bed Coating and Granulation for CR Delivery (Yue Teng and Zhihui Qiu). 9 Controlled Release using Bilayer Osmotic Tablet Technology: Reducing Theory to Practice (Sheri L Shamblin). 10 Fast Disintegrating Tablets (Seong Hoon Jeong, Jaehwi Lee, and Jong Soo Woo). 11 Buccal Drug Delivery Systems (John D. Smart and Gemma Keegan). 12 Oral Targeted Drug Delivery Systems: Gastric Retention Devices (Hamid Omidian and Kinam Park). 13 Oral Targeted Drug Delivery Systems: Enteric Coating (Wendy Dulin). 14 Orally Administered Drug Delivery Systems to the Colon (Mirela Nadler Milabuer, Yossi Kam and Abraham Rubinstein). 15 Dissolution Testing: In Vitro Characterization of Oral Controlled Release Dosage Forms (Michele Xuemei Guo). 16 Challenges and New Technologies of Oral Controlled Release (Xiaoming Chen, Hong Wen and Kinam Park). 17 Oral Controlled Drug Delivery: Quality By Design (QbD) Approach to Drug Development (Shailesh Singh, Thirunellai G. Venkateshwaran and Stephen P. Simmons). 18 Oral Controlled Release-Based Products for Life Cycle Management (Nipun Davar and Sangita Ghosh). 19 Generic Oral Controlled Release Product Development: Formulation and Process Considerations (Salah U. Ahmed and Venkatesh Naini). 20 The Science and Regulatory Perspectives of Emerging Controlled Release Dosage Forms (Rakhi B. Shah and Mansoor A. Khan). Index.
Preface. Contributors. 1 Introduction and Overview of Oral Controlled Release Formulation Design (Hong Wen and Kinam Park). 2 Evolution of Oral Controlled Release Dosage Forms (Ping I. Lee and Jian-Xin Li). 3 Biopharmaceutic Consideration and Assessment for Oral Controlled Release (CR) Formulations (Hua Zhang and Jean M. Surian). 4 Preformulation Consideration for Drugs in Oral CR Formulation (Manching Sherry Ku). 5 Polymers in Oral Modified Release Systems (Jiasheng Tu, Yan Shen, Ravichandran Mahalingam, Bhaskara Jasti, and Xiaoling Li). 6 Oral Extended Release Hydrophilic Matrices: Formulation and Design (Xiaoguang Wen, Ali Nokhodchi, and Ali Rajabi-Siahboomi). 7 Coating Systems for Oral Controlled Release Formulations (Linda A. Felton). 8 Fluid Bed Coating and Granulation for CR Delivery (Yue Teng and Zhihui Qiu). 9 Controlled Release using Bilayer Osmotic Tablet Technology: Reducing Theory to Practice (Sheri L Shamblin). 10 Fast Disintegrating Tablets (Seong Hoon Jeong, Jaehwi Lee, and Jong Soo Woo). 11 Buccal Drug Delivery Systems (John D. Smart and Gemma Keegan). 12 Oral Targeted Drug Delivery Systems: Gastric Retention Devices (Hamid Omidian and Kinam Park). 13 Oral Targeted Drug Delivery Systems: Enteric Coating (Wendy Dulin). 14 Orally Administered Drug Delivery Systems to the Colon (Mirela Nadler Milabuer, Yossi Kam and Abraham Rubinstein). 15 Dissolution Testing: In Vitro Characterization of Oral Controlled Release Dosage Forms (Michele Xuemei Guo). 16 Challenges and New Technologies of Oral Controlled Release (Xiaoming Chen, Hong Wen and Kinam Park). 17 Oral Controlled Drug Delivery: Quality By Design (QbD) Approach to Drug Development (Shailesh Singh, Thirunellai G. Venkateshwaran and Stephen P. Simmons). 18 Oral Controlled Release-Based Products for Life Cycle Management (Nipun Davar and Sangita Ghosh). 19 Generic Oral Controlled Release Product Development: Formulation and Process Considerations (Salah U. Ahmed and Venkatesh Naini). 20 The Science and Regulatory Perspectives of Emerging Controlled Release Dosage Forms (Rakhi B. Shah and Mansoor A. Khan). Index.
Rezensionen
"This book differs from most in its focus on oral controlled release formulation design and process development. It also covers the related areas like preformulation, biopharmaceutics, in vitro-in vivo correlations (IVIVC), quality by design (QbD), and regulatory issues". (Yahoo! Finance US, 19 January 2011)
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Shop der buecher.de GmbH & Co. KG Bürgermeister-Wegele-Str. 12, 86167 Augsburg Amtsgericht Augsburg HRA 13309
